Isabella Ciccone, Assistant Editor, NeurologyLive®, has been with the team since September 2022. Follow her on Twitter @iciccone7 or email her at firstname.lastname@example.org
Autologous Hematopoietic Stem Cell Transplantation Fails to Show Superiority to Natalizumab as a Treatment for Progressive MSOctober 28th 2022
Presented as an oral late breaker by Tomas Kalincik, MD, PhD, autologous hematopoietic stem cell transplantation was not superior to natalizumab in the reduction of disability progression in patients with progressive MS.
Inadequate Sleep Related to Neurocognitive Difficulties for Children with InsomniaOctober 24th 2022
Fan Nils Yang, PhD, postdoctoral researcher, University of Maryland, provides greater detail on the observational cohort study he did with colleagues, where they identified a link between neurocognitive function in children and insomnia.
Melatonin Treatment Approved by MHRA for Children With ADHD and Sleep Onset InsomniaOctober 20th 2022
Based on a trial that showed melatonin improved total sleep time in children with ADHD and sleep onset insomnia, Colonis’ Melatonin 1mg/ml Oral Solution was approved by the MHRA in the United Kingdom.
Presence of Insomnia Symptoms Associated With Alcohol-Related HarmOctober 13th 2022
A survey based on young adult college students indicated that symptoms of insomnia might buffer the association with the acute physiological effects of alcohol, in part because it may heighten the sensitivity to alcohol.
Longer Periods Between Natalizumab Dosing Might Result in Increased T2 Lesion CountOctober 11th 2022
New data from the NOVA trial showed differences in the number of T2 lesions in patients with relapsing-remitting multiple sclerosis at 72 weeks of treatment with natalizumab (Tysabri; Biogen), though seemingly driven by data from only 2 participants with extreme new or newly enlarging T2 hyperintense lesion numbers.
Combination of MSBASE Prediction Model and Multiple Sclerosis Severity Score Improves Accuracy of Individualized Prediction in MSOctober 8th 2022
Data from a MSbase registry on patients with multiple sclerosis show in its findings that the incorporation of the Multiple Sclerosis Severity Score improved the prediction accuracy of relapses in MS.
Combination of Biomarkers Associated with Stronger Predictions of Progression in Parkinson DiseaseOctober 8th 2022
Findings from a study on Parkinson disease revealed that combining blood biomarkers in addition with clinical measures with prognostics modelling are associated with a more vital prediction in disease progression.
Majority of Canadian Physicians Treat Primary Headache Disorders With Nonsteroidal Anti-inflammatory Drugs, Dopamine Receptor AntagonistsOctober 5th 2022
A national survey showed in its findings that NSAIDs alone and dopamine receptor antagonists are used commonly for treating primary headache disorders in Canadian emergency departments.
Ketogenic Diet Results in Reduced Weight, Fatigue, and Depression in Relapsing Multiple SclerosisOctober 5th 2022
In a recent phase 2 study, 6-months of ketogenic diet for people with relapsing multiple sclerosis resulted in a significant reduction in weight, fatigue, and depression, and improved quality of life.
Nonpharmacologic Interventions Improve Sleep Time in Hospitalized PatientsOctober 3rd 2022
Findings from a nonrandomized controlled trial in the Netherlands suggest that sleep time of hospitalized patients may be significantly improved with nonpharmacologic interventions such as the postponement of morning vital sign checks and medication administration rounds from the night to the day shift.